Sanofi and MannKind Enter Global Licensing Agreement for Afrezza Insulin

13.08.2014 - Sanofi and MannKind Corporation have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza (insulin human) Inhalation Powder, a...